Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Oct 27, 2022; 14(10): 1120-1130
Published online Oct 27, 2022. doi: 10.4240/wjgs.v14.i10.1120
Published online Oct 27, 2022. doi: 10.4240/wjgs.v14.i10.1120
Table 1 Basic patient information and distribution of internal hemorrhoids
| Basic situation | Follow-up of 2020 (n = 201) | Follow-up of 2021 (n = 149) |
| Median follow-up | 33 (24-45) | 45 (34-57) |
| Age | 54.71 ± 13.016 | 54.77 ± 13.495 |
| Gender, n (%) | ||
| Male | 116 (57.7) | 92 (61.7) |
| Female | 85 (42.3) | 57 (38.3) |
| Hemorrhoids installment, n (%) | ||
| Stage Ⅰ | 88 (43.8) | 67 (45.0) |
| Stage Ⅱ | 53 (26.4) | 38 (25.5) |
| Stage Ⅲ | 50 (24.8) | 37 (24.8) |
| Stage Ⅳ | 10 (5.0) | 7 (4.7) |
- Citation: Xie YT, Yuan Y, Zhou HM, Liu T, Wu LH, He XX. Long-term efficacy and safety of cap-assisted endoscopic sclerotherapy with long injection needle for internal hemorrhoids. World J Gastrointest Surg 2022; 14(10): 1120-1130
- URL: https://www.wjgnet.com/1948-9366/full/v14/i10/1120.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i10.1120